Chemoinformaics analysis of 15-NORCARYOPHYLLEN-3-ONE
| Molecular Weight | 206.329 | nRot | 0 |
| Heavy Atom Molecular Weight | 184.153 | nRig | 13 |
| Exact Molecular Weight | 206.167 | nRing | 2 |
| Solubility: LogS | -4.448 | nHRing | 0 |
| Solubility: LogP | 4.287 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 38.8514 |
| nHD | 0 | BPOL | 22.9386 |
| QED | 0.552 |
| Synth | 4.007 |
| Natural Product Likeliness | 2.633 |
| NR-PPAR-gamma | 0.017 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.047 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.535 |
| MDCK | 0.0000165 |
| BBB | 0.914 |
| PPB | 0.950713 |
| VDSS | 2.582 |
| FU | 0.0341894 |
| CYP1A2-inh | 0.203 |
| CYP1A2-sub | 0.515 |
| CYP2c19-inh | 0.257 |
| CYP2c19-sub | 0.835 |
| CYP2c9-inh | 0.278 |
| CYP2c9-sub | 0.939 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.764 |
| CYP3a4-inh | 0.045 |
| CYP3a4-sub | 0.232 |
| CL | 15.38 |
| T12 | 0.295 |
| hERG | 0.016 |
| Ames | 0.011 |
| ROA | 0.216 |
| SkinSen | 0.219 |
| Carcinogencity | 0.405 |
| EI | 0.666 |
| Respiratory | 0.177 |
| NR-Aromatase | 0.014 |
| Antiviral | Yes |
| Prediction | 0.790715 |